Skip to content

Stay Informed

Subscribe to our newsletter for the latest updates on child health and pediatric clinical research.

Subscribe We respect your privacy. Unscubscribe at any time
Close
home button
Search
  • Home
  • Who We Are
    • Funding
    • Organization
    • Research Sites Map
  • What We Do
    • News
    • PTN Studies
    • PTN Methods
    • Future Research
  • Our Impact
    • FDA Label Changes
    • Publications
    • PTN and INCLUDE
    • Data Sharing
    • PTN and iCAN Collaboration
    • Results At-A-Glance
  • Resources
    • Parents, Families, and Caregivers
    • Researchers
Stay Informed

Pediatric Trials Network

PTN

Physiologically Based Pharmacokinetic Modeling to Characterize the Disposition of Topiramate in Children with and without Obesity

Posted on October 16, 2026October 16, 2026 by Jeannine Sato

Journal of Clinical Pharmacology, October 2026

Access article on PubMed

This entry was posted in Anti-epileptic obesity, Antiepileptics, Obesity, Pharmacokinetics, Publications, Seizures and tagged Antiepileptic_obesity. Bookmark the permalink.

Post navigation

← Oxcarbazepine Results-at-a-Glance video
Pantoprazole Results-at-a-Glance video →

Quick Links

  • Organization
  • PTN Studies
  • Publications

Resources

  • Parents, Families, and Caregivers
  • Researchers
    • Contact Us
    LinkedIn
    • test
    Privacy Statement
    WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.